chr1-151574340-T-C
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_020127.3(TUFT1):āc.665T>Cā(p.Val222Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000268 in 1,613,558 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_020127.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TUFT1 | NM_020127.3 | c.665T>C | p.Val222Ala | missense_variant | 8/13 | ENST00000368849.8 | NP_064512.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TUFT1 | ENST00000368849.8 | c.665T>C | p.Val222Ala | missense_variant | 8/13 | 1 | NM_020127.3 | ENSP00000357842.3 | ||
TUFT1 | ENST00000368848.6 | c.590T>C | p.Val197Ala | missense_variant | 7/12 | 1 | ENSP00000357841.2 | |||
TUFT1 | ENST00000392712.7 | c.500T>C | p.Val167Ala | missense_variant | 6/11 | 5 | ENSP00000376476.3 | |||
TUFT1 | ENST00000490156.1 | n.492T>C | non_coding_transcript_exon_variant | 3/4 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000218 AC: 33AN: 151568Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000530 AC: 133AN: 251122Hom.: 0 AF XY: 0.000656 AC XY: 89AN XY: 135714
GnomAD4 exome AF: 0.000274 AC: 400AN: 1461872Hom.: 0 Cov.: 30 AF XY: 0.000311 AC XY: 226AN XY: 727242
GnomAD4 genome AF: 0.000218 AC: 33AN: 151686Hom.: 0 Cov.: 31 AF XY: 0.000202 AC XY: 15AN XY: 74118
ClinVar
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 18, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at